MENU
PLRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Pliant Therapeutics (PLRX) Ownership - Who owns Pliant Therapeutics?
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases... Show more
Profile
Industry
N/A
Address
260 Littlefield Avenue
Phone
+1 650 481-6770
Employees
158
Web
https://www.pliantrx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
96.38M
P/E Ratio
N/A
Total Cash
355.72M
Projected Growth
N/A
Total Debt
60.19M
Revenue
N/A
Risk (Beta)
1.76
Dividend Yield
N/A
Total Cash/Share
5.79
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
PLRX
Capitalization
96.4M
P/E Ratio
N/A
Risk (Beta)
1.76
Dividend Yield
N/A
Total Cash
356M
Total Cash/Share
5.79
Total Debt
60.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
304M
P/B Ratio
0.32
Cash Flow
N/A
Earnings
-3.47
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
10.91
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-205.16M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-46.27
Shares Held By Institutions
1.04B
Shares Outstanding - Current
61.4M
Total Liabilities
92.9M
Total Volume MTD
N/A
Value
-1
Gain YTD
-88.079
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company which engages in the business of developing and commercializing novel therapies for fibrotic diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
260 Littlefield Avenue
Phone
+1 650 481-6770
Employees
158
Web
https://www.pliantrx.com